Groeneveld GJ - Search Results

1

A validated HPLC assay to monitor riluzole plasma or serum concentrations in patients with amyotrophic lateral sclerosis.

van Kan HJ, Spieksma M, Groeneveld GJ, Toraño JS, van den Berg LH, Guchelaar HJ. van Kan HJ, et al. Among authors: groeneveld gj. Biomed Chromatogr. 2004 Nov;18(9):723-6. doi: 10.1002/bmc.384. Biomed Chromatogr. 2004. PMID: 15386583

2

Inter- and intraindividual variability of riluzole serum concentrations in patients with ALS.

Groeneveld GJ, van Kan HJ, Toraño JS, Veldink JH, Guchelaar HJ, Wokke JH, van den Berg LH. Groeneveld GJ, et al. J Neurol Sci. 2001 Oct 15;191(1-2):121-5. doi: 10.1016/s0022-510x(01)00613-x. J Neurol Sci. 2001. PMID: 11677002 Clinical Trial.

3

Riluzole serum concentrations in patients with ALS: associations with side effects and symptoms.

Groeneveld GJ, Van Kan HJ, Kalmijn S, Veldink JH, Guchelaar HJ, Wokke JH, Van den Berg LH. Groeneveld GJ, et al. Neurology. 2003 Oct 28;61(8):1141-3. doi: 10.1212/01.wnl.0000090459.76784.49. Neurology. 2003. PMID: 14581684 Clinical Trial.

4

Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis.

van Kan HJ, Groeneveld GJ, Kalmijn S, Spieksma M, van den Berg LH, Guchelaar HJ. van Kan HJ, et al. Among authors: groeneveld gj. Br J Clin Pharmacol. 2005 Mar;59(3):310-3. doi: 10.1111/j.1365-2125.2004.02233.x. Br J Clin Pharmacol. 2005. PMID: 15752377 Free PMC article.

5

An association study of riluzole serum concentration and survival and disease progression in patients with ALS.

Groeneveld GJ, van Kan HJ, Lie-A-Huen L, Guchelaar HJ, van den Berg LH. Groeneveld GJ, et al. Clin Pharmacol Ther. 2008 May;83(5):718-22. doi: 10.1038/sj.clpt.6100382. Epub 2007 Sep 26. Clin Pharmacol Ther. 2008. PMID: 17898704

6

Pharmacokinetics of riluzole: evidence for glucuronidation as a major metabolic pathway not associated with UGT1A1 genotype.

van Kan HJ, van den Berg LH, Groeneveld GJ, van der Straaten RJ, van Vught PW, Lie-A-Huen L, Guchelaar HJ. van Kan HJ, et al. Among authors: groeneveld gj. Biopharm Drug Dispos. 2008 Apr;29(3):139-44. doi: 10.1002/bdd.594. Biopharm Drug Dispos. 2008. PMID: 18098330 Clinical Trial.

7

Acute Effects of Riluzole and Retigabine on Axonal Excitability in Patients With Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.

Kovalchuk MO, Heuberger JAAC, Sleutjes BTHM, Ziagkos D, van den Berg LH, Ferguson TA, Franssen H, Groeneveld GJ. Kovalchuk MO, et al. Among authors: groeneveld gj. Clin Pharmacol Ther. 2018 Dec;104(6):1136-1145. doi: 10.1002/cpt.1096. Epub 2018 Jun 19. Clin Pharmacol Ther. 2018. PMID: 29672831 Clinical Trial.

8

Sequential designs for clinical trials in amyotrophic lateral sclerosis.

Groeneveld GJ, van der Tweel I, Wokke JH, van den Berg LH. Groeneveld GJ, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Dec;5(4):202-7. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004. PMID: 15799547

9

Alternative trial design in amyotrophic lateral sclerosis saves time and patients.

Groeneveld GJ, Graf M, van der Tweel I, van den Berg LH, Ludolph AC. Groeneveld GJ, et al. Amyotroph Lateral Scler. 2007 Oct;8(5):266-9. doi: 10.1080/17482960701419497. Amyotroph Lateral Scler. 2007. PMID: 17852016 Clinical Trial.

10

A randomized sequential trial of creatine in amyotrophic lateral sclerosis.

Groeneveld GJ, Veldink JH, van der Tweel I, Kalmijn S, Beijer C, de Visser M, Wokke JH, Franssen H, van den Berg LH. Groeneveld GJ, et al. Ann Neurol. 2003 Apr;53(4):437-45. doi: 10.1002/ana.10554. Ann Neurol. 2003. PMID: 12666111 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters